US Stock MarketDetailed Quotes
ABEO Abeona Therapeutics
- 4.1000
- +0.0400+0.99%
Close May 28 16:00 ET
- 4.1600
- +0.0600+1.46%
Post 18:06 ET
168.86MMarket Cap-1301P/E (TTM)
4.2100High4.0200Low461.70KVolume4.1300Open4.0600Pre Close1.90MTurnover1.51%Turnover RatioLossP/E (Static)41.19MShares9.010052wk High-18.98P/B125.13MFloat Cap2.830052wk Low--Dividend TTM30.52MShs Float171874.8797Historical High--Div YieldTTM4.68%Amplitude2.1900Historical Low4.1170Avg Price1Lot Size
Abeona Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 147.52%3.5M | 0 | 0 | 250.00%3.5M | 0 | -52.87%1.41M | -97.73%68K | 0 | 1M |
| Operating revenue | --0 | 147.52%3.5M | --0 | --0 | 250.00%3.5M | --0 | -52.87%1.41M | -97.73%68K | --0 | --1M |
| Cost of revenue | 256.67%1.61M | 0 | 30K | 350.00%1.58M | 450K | 100K | 0 | 350K | ||
| Gross profit | 96.58%1.9M | 0 | -30K | 196.15%1.93M | -67.87%964K | -101.07%-32K | 0 | 650K | ||
| Operating expense | 19.04%14.33M | 8.38%50.1M | 10.50%13.21M | 20.51%11.3M | 33.86%13.54M | -18.49%12.04M | -23.44%46.22M | -30.44%11.95M | -36.93%9.38M | -26.23%10.12M |
| Selling and administrative expenses | 78.21%7.12M | 10.13%19M | 2.60%5.83M | 6.84%4.16M | 45.12%5.02M | -5.37%4M | -20.27%17.26M | 29.64%5.68M | -33.12%3.89M | -33.23%3.46M |
| -General and administrative expense | 78.21%7.12M | 10.13%19M | 2.60%5.83M | 6.84%4.16M | 45.12%5.02M | -5.37%4M | -20.27%17.26M | 29.64%5.68M | -33.12%3.89M | -33.23%3.46M |
| Research and development costs | -10.37%7.21M | 7.34%31.09M | 17.65%7.38M | 30.20%7.15M | 28.01%8.52M | -23.75%8.04M | -25.21%28.97M | -51.01%6.27M | -39.38%5.49M | -21.97%6.66M |
| Operating profit | -19.04%-14.33M | -6.50%-48.2M | -10.20%-13.21M | -20.83%-11.33M | -22.72%-11.62M | 16.54%-12.04M | 21.11%-45.26M | 15.51%-11.99M | 36.93%-9.38M | 30.97%-9.47M |
| Net non-operating interest income expense | -141.44%-109K | 657.05%1.7M | 322.67%634K | 674.12%488K | 285.80%314K | 235.57%263K | 91.57%-305K | 412.50%150K | 87.43%-85K | 88.67%-169K |
| Non-operating interest income | 131.59%843K | 391.18%2.12M | 126.52%743K | 723.61%593K | 1,245.16%417K | 5,100.00%364K | 977.50%431K | 6,460.00%328K | 928.57%72K | 287.50%31K |
| Non-operating interest expense | 842.57%952K | -43.21%418K | -38.76%109K | -33.12%105K | -48.50%103K | -49.75%101K | -79.87%736K | 235.85%178K | -77.01%157K | -86.67%200K |
| Other net income (expense) | -742.39%-17.14M | -231.04%-7.69M | -185.17%-4.02M | -132.66%-990K | -196.55%-5.35M | 135.92%2.67M | 124.49%5.87M | 114.53%4.72M | -64.36%3.03M | 5.54M |
| Gain on sale of security | -863.84%-17.3M | -202.74%-11.7M | -178.51%-4.23M | -136.10%-1.1M | -305.55%-8.63M | 280.77%2.27M | --11.38M | --5.39M | --3.05M | --4.2M |
| Special income (charges) | ---- | 118.82%1.07M | --0 | --0 | -27.05%1.07M | ---- | 76.39%-5.66M | 97.07%-950K | --0 | --1.46M |
| -Less:Impairment of capital assets | ---- | --0 | --0 | --0 | --0 | ---- | -90.31%3.15M | --0 | --0 | ---1.46M |
| -Gain on sale of property,plant,equipment | ---- | 142.41%1.07M | --0 | --0 | --1.07M | ---- | ---2.51M | ---950K | --0 | --0 |
| Other non- operating income (expenses) | -59.80%162K | 1,987.23%2.94M | -22.74%214K | 684.21%111K | 1,977.12%2.22M | 6,816.67%403K | 840.00%141K | 1,529.41%277K | -733.33%-19K | ---118K |
| Income before tax | -246.74%-31.58M | -36.51%-54.19M | -132.99%-16.59M | -83.96%-11.84M | -306.49%-16.65M | 58.69%-9.11M | 53.26%-39.7M | 84.75%-7.12M | 8.66%-6.43M | 73.06%-4.1M |
| Income tax | ||||||||||
| Net income | -246.74%-31.58M | -36.51%-54.19M | -132.99%-16.59M | -83.96%-11.84M | -306.49%-16.65M | 58.69%-9.11M | 53.26%-39.7M | 84.75%-7.12M | 8.66%-6.43M | 73.06%-4.1M |
| Net income continuous Operations | -246.74%-31.58M | -36.51%-54.19M | -132.99%-16.59M | -83.96%-11.84M | -306.49%-16.65M | 58.69%-9.11M | 53.26%-39.7M | 84.75%-7.12M | 8.66%-6.43M | 73.06%-4.1M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -246.74%-31.58M | -36.51%-54.19M | -132.99%-16.59M | -83.96%-11.84M | -306.49%-16.65M | 58.69%-9.11M | 53.26%-39.7M | 84.75%-7.12M | 8.66%-6.43M | 73.06%-4.1M |
| Preferred stock dividends | 3.78M | 0 | 3.78M | |||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -246.74%-31.58M | -24.63%-54.19M | -132.99%-16.59M | -83.96%-11.84M | -111.37%-16.65M | 58.69%-9.11M | 48.81%-43.48M | 84.75%-7.12M | 8.66%-6.43M | 48.19%-7.88M |
| Basic earnings per share | -114.81%-1.16 | 54.25%-2.53 | -59.26%-0.64 | 52.00%-0.48 | 32.35%-0.92 | 85.79%-0.54 | 74.36%-5.53 | 96.43%-0.4019 | 44.44%-1 | 65.39%-1.36 |
| Diluted earnings per share | -114.81%-1.16 | 54.25%-2.53 | -59.26%-0.64 | 52.00%-0.48 | 32.35%-0.92 | 85.79%-0.54 | 74.36%-5.53 | 96.43%-0.4019 | 44.44%-1 | 65.39%-1.36 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg